The patent, No. 8,808,751, covers the company’s dry milling method for producing submicron-sized particles that are 10 to 200 times smaller than conventional drug particles. "This patent further
As such, the claims provide broad coverage for all opioids and other drugs prone to abuse that could leverage the DETERx technology platform. This is the sixth issued
In a poster on Monday, September 22, "Discovery and characterization of super-enhancer-associated dependencies in acute myeloid leukemia (AML)," Syros scientists demonstrated that by examining the entire genomes of
Highlights New campus will be located at intersection of Princeton Pike and Interstate 295 Construction is expected to begin this fall with occupancy planned by the end of
The study demonstrating that topical application of pterostilbene onto mouse skin, prior to UV exposure, prevented several types of UV-mediated damage. Specifically, pterostilbene prevented UV-mediated DNA damage, reddening
This multi-centre, placebo-controlled clinical trial (Protocol TRx-237-005) is aimed at assessing the efficacy of LMTX in people diagnosed with mild Alzheimer’s disease. The study is also evaluating the
Concurrently, the Company announced a new corporate management team and its intention to strategically refocus and rebrand the company as PlasmaTech Biopharmaceuticals, Inc.™, and its plans to pursue
With an ED market that brings in billions annually, it’s not hard to figure out why Plandaí would use its unique and proprietary extraction process to try to
Clinical Ink’s SureSource will replace paper scales with fully electronic questionnaires incorporating built-in logic, automated scoring, and integrated audio recordings to improve the assessment of critical efficacy endpoints.
The programs will focus on ‘last-mile’ interventions to reach underserved populations living in Ethiopia, Malawi, Rwanda, Uganda and Zambia. Grant recipients include UNICEF, Save the Children and International
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.